Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency

被引:197
作者
Bensing, Sophie [1 ,2 ]
Brandt, Lena [3 ]
Tabaroj, Farnoush [2 ]
Sjoberg, Olof [4 ]
Nilsson, Bo [4 ]
Ekbom, Anders [3 ]
Blomqvist, Paul [3 ]
Kampe, Olle [2 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[2] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
[3] Karolinska Univ Hosp, Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden
[4] Univ Uppsala Hosp, Dept Clin Immunol, Uppsala, Sweden
基金
瑞典研究理事会;
关键词
D O I
10.1111/j.1365-2265.2008.03340.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Primary adrenocortical insufficiency is mostly caused by an autoimmune destruction of the adrenal cortex. The disease may appear isolated or as a part of an autoimmune polyendocrine syndrome (APS). APS1 is a rare hereditary disorder with a broad spectrum of clinical manifestations. In APS2, primary adrenocortical insufficiency is often combined with autoimmune thyroid disease and/or type 1 diabetes. We analysed mortality and cancer incidence in primary adrenocortical insufficiency patients during 40 years. Data were compared with the general Swedish population. Design and patients A population based cohort study including all patients with autoimmune primary adrenocortical insufficiency (3299) admitted to Swedish hospitals 1964-2004. Measurements Mortality risk was calculated as the standardized mortality ratio (SMR) and cancer incidence as the standardized incidence ratio (SIR). Results A more than 2-fold increased mortality risk was observed in both women (SMR 2.9, 95% CI 2.7-3.0) and men (SMR 2.5, 95% CI 2.3-2.7). Highest risks were observed in patients diagnosed in childhood. SMR was higher in APS1 patients (SMR 4.6, 95% CI 3.5-6.0) compared with patients with APS2 (SMR 2.1, 95% CI 1.9-2.4). Cancer incidence was increased (SIR 1.3, 95% CI 1.2-1.5). When tumours observed during the first year of follow-up were excluded, only the cancer risk among APS1 patients remained increased. Cause-specific cancer incidence analysis revealed significantly higher incidences of oral cancer, nonmelanoma skin cancer, and male genital system cancer among patients. Breast cancer incidence was lower than in the general population. Conclusions Our study shows a reduced life expectancy and altered cancer incidence pattern in patients with autoimmune primary adrenocortical insufficiency.
引用
收藏
页码:697 / 704
页数:8
相关论文
共 29 条
[1]   An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains [J].
Aaltonen, J ;
Bjorses, P ;
Perheentupa, J ;
HorelliKuitunen, N ;
Palotie, A ;
Peltonen, L ;
Lee, YS ;
Francis, F ;
Hennig, S ;
Thiel, C ;
Lehrach, H ;
Yaspo, ML .
NATURE GENETICS, 1997, 17 (04) :399-403
[2]   Risk of haematopoietic cancer in patients with inflammatory bowel disease [J].
Askling, J ;
Brandt, L ;
Lapidus, A ;
Karlén, P ;
Björkholm, M ;
Löfberg, R ;
Ekbom, A .
GUT, 2005, 54 (05) :617-622
[3]   Premature mortality in patients with Addison's disease: A population-based study [J].
Bergthorsdottir, Ragnhildur ;
Leonsson-Zachrisson, Maria ;
Oden, Anders ;
Johannsson, Gudmundur .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (12) :4849-4853
[4]   Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison's disease: Comparison of immunofluorescence and immunoprecipitation assays [J].
Betterle, C ;
Volpato, M ;
Pedini, B ;
Chen, S ;
Smith, BR ;
Furmaniak, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) :618-622
[5]   Why is the management of glucocorticoid deficiency still controversial: a review of the literature [J].
Crown, A ;
Lightman, S .
CLINICAL ENDOCRINOLOGY, 2005, 63 (05) :483-492
[6]   Medical progress - Autoimmune polyendocrine syndromes [J].
Eisenbarth, GS ;
Gottlieb, PA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (20) :2068-2079
[7]   Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives [J].
Ekström, K ;
Hjalgrim, H ;
Brandt, L ;
Baecklund, E ;
Klareskog, L ;
Ekbom, A ;
Askling, J .
ARTHRITIS AND RHEUMATISM, 2003, 48 (04) :963-970
[8]   HIGH DIAGNOSTIC-ACCURACY FOR IDIOPATHIC ADDISONS-DISEASE WITH A SENSITIVE RADIOBINDING ASSAY FOR AUTOANTIBODIES AGAINST RECOMBINANT HUMAN 21-HYDROXYLASE [J].
FALORNI, A ;
NIKOSHKOV, A ;
LAURETI, S ;
GRENBACK, E ;
HULTING, AL ;
CASUCCI, G ;
SANTEUSANIO, F ;
BRUNETTI, P ;
LUTHMAN, H ;
LERNMARK, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (09) :2752-2755
[9]   Age at natural menopause and all-cause mortality:: A 37-year follow-up of 19,731 Norwegian women [J].
Jacobsen, BK ;
Heuch, I ;
Kvåle, G .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (10) :923-929
[10]   Oral cancer [J].
Kademani, Deepak .
MAYO CLINIC PROCEEDINGS, 2007, 82 (07) :878-887